浙江司太立制药股份有限公司
Zhejiang Starry Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
11
14 products shown
🇺🇸 DMF
7
7 products shown
🇪🇺 CEP
7
7 products shown
Total
25
registrations
🇨🇳 CDE 注册 (14)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Gadobutrol 钆布醇 | 770691-21-9 | Class I | Y20260000022 |
| Iodixanol 碘克沙醇 | 92339-11-2 | Class A | Y20190005421 |
| Iohexol 碘海醇 | 66108-95-0 | Class A | Y20190007790 |
| Iomeprol 碘美普尔 | 78649-41-9 | Class A | Y20180000463 |
| Iopamidol 碘帕醇 | 60166-93-0 | Class A | Y20210001209 |
| Iopamidol 碘帕醇 | 60166-93-0 | Class A | Y20190009889 |
| Iopamidol 碘帕醇 | 60166-93-0 | Class I | Y20180001432 |
| Iopromide 碘普罗胺 | 73334-07-3 | Class A | Y20230000873 |
| Ioversol 碘佛醇 | 87771-40-2 | Class A | Y20180000462 |
| Levofloxacin 左氧氟沙星 | 100986-85-4 | Class A | Y20190009874 |
| Levofloxacin 左氧氟沙星 | 100986-85-4 | Class A | Y20180001433 |
| Loxoprofen Sodium 洛索洛芬钠 | 68767-14-6 | Class A | Y20220000226 |
| Ofloxacin 氧氟沙星 | 82419-36-1 | Class A | Y20190006264 |
| Regadenoson 瑞加诺生 | 313348-27-5 | Class A | Y20220000249 |
🇺🇸 DMF 注册 (7)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Acetoiodide | - | 33208 | 2019-04-09 |
| Hydroxyacetyl Iodide | - | 33977 | 2019-09-10 |
| Iodixanol USP 碘克沙醇 | 92339-11-2 | 36468 | 2022-01-14 |
| Iohexol 碘海醇 | 66108-95-0 | 22535 | 2009-02-23 |
| Iohexol USP 碘海醇 | 66108-95-0 | 36038 | 2021-09-15 |
| Iopamidol 碘帕醇 | 60166-93-0 | 28033 | 2013-12-23 |
| Iopamidol USP 碘帕醇 | 60166-93-0 | 36683 | 2022-01-24 |
🇪🇺 CEP 注册 (7)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Iodixanol 碘克沙醇 | 92339-11-2 | R0-CEP 2022-027 - Rev 00 | 2023-06-20 |
| Iohexol 碘海醇 | 66108-95-0 | R1-CEP 2009-018 - Rev 02 | 2018-02-08 |
| Iohexol, Process 2 碘海醇 | 66108-95-0 | R0-CEP 2021-313 - Rev 00 | 2022-03-02 |
| Iopamidol 碘帕醇 | 60166-93-0 | R1-CEP 2013-267 - Rev 00 | 2019-09-26 |
| Iopamidol, Process 2 碘帕醇 | 60166-93-0 | R0-CEP 2022-050 - Rev 01 | 2023-08-16 |
| Iopromide 碘普罗胺 | 73334-07-3 | CEP 2022-232 - Rev 01 | 2025-05-02 |
| Levofloxacin Hemihydrate 左氧氟沙星（供注射用） | 138199-71-0 | R0-CEP 2022-059 - Rev 00 | 2023-08-30 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12